Purple Biotech Stock Quote PPBT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.374

Bid

0.3047

Ask

0.388

Volume

86,428

0.36 Day's Range 0.39

0.00 52 Week Range 0.00

Market Cap

9.202M

Previous Close

0.3646

Open

0.38

Last Trade

100

0.374

(formt)

Last Trade Time

Financial Volume

$ 32,072

VWAP

0.371079

Average Volume (3m)

Shares Outstanding

25,237,922

Dividend Yield

PE Ratio

Earnings Per Share (EPS)

Revenue

Net Profit

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24. Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Sector

Pharmaceutical Preparations

Industry

Arrange Trans-freight, Cargo

Website

www.purple-biotech.com

Headquarters

Rehovot, Center, Isr

Founded

2013

Purple Biotech Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PPBT. The last closing price for Purple Biotech was $0.36. Over the last year, Purple Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Purple Biotech currently has 25,237,922 shares outstanding. The market capitalization of Purple Biotech is $9.20 million.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form D - Notice of Exempt Offering of Securities

Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results from Phase 2 Pancreatic Cancer Study with CM24 on July 11, 2024

REHOVOT, Israel, July 10, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class oncology...

Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds

REHOVOT, Israel, July 02, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...

Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds

REHOVOT, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...

Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit

New data suggests that baseline serum myeloperoxidase (MPO) levels below the threshold may predict overall survival (OS) improvement when comparing the CM24+nivolumab+Nal-IRI/5FU/LV vs...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 7.51 (185.55%)	262.73M
AUGXAugmedix Inc	$ 2.27 (147.71%)	21.87M
XCURExicure Inc	$ 0.5351 (76.02%)	14.02M
PSNLPersonalis Inc	$ 3.83 (56.33%)	22.76M
MDBHMDB Capital Holdings LLC	$ 10.675 (37.21%)	126.13k
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	124.61M
HYZNHyzon Motors Inc	$ 0.149 (-47.54%)	23.63M
MEDSTRxADE Health Inc	$ 14.92 (-33.45%)	223.27k
SILOSilo Pharma Inc	$ 2.50 (-27.95%)	11.93M
KITTNauticus Robotics Inc	$ 0.0935 (-27.46%)	28.43M
SERVServe Robotics Inc	$ 7.51 (185.55%)	262.73M
NVDANVIDIA Corporation	$ 117.93 (-2.61%)	206.41M
SXTP60 Degrees Pharmaceuticals Inc	$ 0.2602 (5.77%)	202.14M
SQQQProShares UltraPro Short QQQ	$ 8.46 (2.79%)	184.21M
SPWRSunPower Corporation	$ 0.6735 (-55.40%)	119.98M